Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

CLINICAL REPORTS

Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO)

Gil, Miguel J.a; de las Peñas, Ramóne; Reynés, Gasparf; Balañá, Carmeg; Peréz-Segura, Pedroh; García-Velasco, Adelaidaj; Mesia, Carlosa; Gallego, Óscarb; Fernández-Chacón, Concepcióni; Martínez-García, Maríac; Herrero, Anak; Andrés, Raquell; Benavides, Manuelm; Quintanar, Teresan; Pérez-Martin, Xavierd

Author Information
doi: 10.1097/CAD.0b013e3283534d3e
  • Buy

Abstract

© 2012 Lippincott Williams & Wilkins, Inc.